Skip to main content
Vericel Corporation (VCEL)
NASDAQ: VCEL · Real-Time Price · USD
56.50
+1.55 (2.82%)
Dec 20, 2024, 4:00 PM EST - Market closed

Vericel Revenue

Vericel had revenue of $57.91M in the quarter ending September 30, 2024, with 27.04% growth. This brings the company's revenue in the last twelve months to $226.84M, up 22.48% year-over-year. In the year 2023, Vericel had annual revenue of $197.52M with 20.17% growth.

Revenue (ttm)
$226.84M
Revenue Growth
+22.48%
P/S Ratio
12.06
Revenue / Employee
$722,433
Employees
314
Market Cap
2.79B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023197.52M33.15M20.17%
Dec 31, 2022164.37M8.18M5.24%
Dec 31, 2021156.18M32.01M25.77%
Dec 31, 2020124.18M6.33M5.37%
Dec 31, 2019117.85M26.99M29.71%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Bausch Health Companies 9.47B
Patterson Companies 6.55B
Amedisys 2.32B
LifeStance Health Group 1.21B
ACADIA Pharmaceuticals 929.24M
iRhythm Technologies 560.03M
Twist Bioscience 312.97M
Merus 35.93M
Revenue Rankings

VCEL News

More News